Literature DB >> 24798461

Exome sequencing identifies compound heterozygous mutations in C12orf57 in two siblings with severe intellectual disability, hypoplasia of the corpus callosum, chorioretinal coloboma, and intractable seizures.

Konrad Platzer1, Irina Hüning, Carolin Obieglo, Thomas Schwarzmayr, Rainer Gabriel, Tim M Strom, Gabriele Gillessen-Kaesbach, Frank J Kaiser.   

Abstract

In patients with genetically heterogeneous disorders such as intellectual disability or epilepsy, exome sequencing is a powerful tool to elucidate the underlying genetic cause. Homozygous and compound heterozygous mutations in C12orf57 have recently been described to cause an autosomal recessive syndromic form of intellectual disability, including agenesis/hypoplasia of the corpus callosum, optic coloboma, and intractable seizures. Here, we report on two siblings from nonconsanguineous parents harboring two compound heterozygous loss-of-function mutations in C12orf57 identified by exome sequencing, including a novel nonsense mutation, and review the patients described in the literature.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  C12orf57 gene; corpus callosum; epilepsy; intellectual disability; intractable seizures; optic coloboma

Mesh:

Year:  2014        PMID: 24798461     DOI: 10.1002/ajmg.a.36592

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  3 in total

1.  Pre- and Postnatal Analysis of Chromosome 1q44 Deletion in Agenesis of Corpus Callosum.

Authors:  Mitesh Shetty; Ambika Srikanth; Jayarama Kadandale; Sridevi Hegde
Journal:  Mol Syndromol       Date:  2015-09-11

Review 2.  Conserved genetic pathways associated with microphthalmia, anophthalmia, and coloboma.

Authors:  Linda M Reis; Elena V Semina
Journal:  Birth Defects Res C Embryo Today       Date:  2015-06-03

3.  Temtamy syndrome caused by a new C12orf57 variant in a Chinese boy, including pedigree analysis and literature review.

Authors:  Yanqin Wang; Ming Li; Yuanyuan Luo; Xin Zhao; Shuang Liao; Li Jiang; Xiujuan Li; Min Zhong
Journal:  Exp Ther Med       Date:  2019-11-12       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.